Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.34 USD | -0.55% | -3.11% | +34.02% |
May. 21 | Immunome Insider Bought Shares Worth $1,388,072, According to a Recent SEC Filing | MT |
May. 20 | Immunome Completes Purchase of Antibodies From Atreca | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.02% | 864M | |
+10.79% | 115B | |
+11.65% | 106B | |
-6.20% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.41% | 17.56B | |
-40.50% | 17.32B | |
+6.64% | 14.03B | |
+31.84% | 12.13B |
- Stock Market
- Equities
- IMNM Stock
- News Immunome, Inc.
- Immunome Appoints Dennis Giesing as Chief Development Officer